276 related articles for article (PubMed ID: 38474211)
1. The Role of Polyphenols in Modulating PON1 Activity Regarding Endothelial Dysfunction and Atherosclerosis.
Sirca TB; Mureșan ME; Pallag A; Marian E; Jurca T; Vicaș LG; Tunduc IP; Manole F; Ștefan L
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474211
[TBL] [Abstract][Full Text] [Related]
2. Variation in paraoxonase-1 activity and atherosclerosis.
Soran H; Younis NN; Charlton-Menys V; Durrington P
Curr Opin Lipidol; 2009 Aug; 20(4):265-74. PubMed ID: 19550323
[TBL] [Abstract][Full Text] [Related]
3. Paraoxonase 1 and atherosclerosis-related diseases.
Kotur-Stevuljević J; Vekić J; Stefanović A; Zeljković A; Ninić A; Ivanišević J; Miljković M; Sopić M; Munjas J; Mihajlović M; Spasić S; Jelić-Ivanović Z; Spasojević-Kalimanovska V
Biofactors; 2020 Mar; 46(2):193-205. PubMed ID: 31400246
[TBL] [Abstract][Full Text] [Related]
4. Paraoxonase, a cardioprotective enzyme: continuing issues.
Getz GS; Reardon CA
Curr Opin Lipidol; 2004 Jun; 15(3):261-7. PubMed ID: 15166781
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the role of paraoxonase gene polymorphism (Q192R) and paraoxonase activity in the susceptibility to atherosclerosis among lead-exposed workers.
Kamal M; Fathy MM; Taher E; Hasan M; Tolba M
Ann Saudi Med; 2011; 31(5):481-7. PubMed ID: 21911985
[TBL] [Abstract][Full Text] [Related]
6. Paraoxonase 1 concerning dyslipidaemia, cardiovascular diseases, and mortality in haemodialysis patients.
Grzegorzewska AE; Adamska P; Iwańczyk-Skalska E; Ostromecka K; Niepolski L; Marcinkowski W; Mostowska A; Warchoł W; Żaba C; Jagodziński PP
Sci Rep; 2021 Mar; 11(1):6773. PubMed ID: 33762698
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on.
Costa LG; Giordano G; Furlong CE
Biochem Pharmacol; 2011 Feb; 81(3):337-44. PubMed ID: 21093416
[TBL] [Abstract][Full Text] [Related]
8. Punicalagin Decreases Serum Glucose Levels and Increases PON1 Activity and HDL Anti-Inflammatory Values in Balb/c Mice Fed a High-Fat Diet.
Atrahimovich D; Samson AO; Khattib A; Vaya J; Khatib S
Oxid Med Cell Longev; 2018; 2018():2673076. PubMed ID: 30151068
[TBL] [Abstract][Full Text] [Related]
9. Interaction between polyphenols intake and PON1 gene variants on markers of cardiovascular disease: a nutrigenetic observational study.
Rizzi F; Conti C; Dogliotti E; Terranegra A; Salvi E; Braga D; Ricca F; Lupoli S; Mingione A; Pivari F; Brasacchio C; Barcella M; Chittani M; D'Avila F; Turiel M; Lazzaroni M; Soldati L; Cusi D; Barlassina C
J Transl Med; 2016 Jun; 14(1):186. PubMed ID: 27338244
[TBL] [Abstract][Full Text] [Related]
10. Role of Paraoxonase1 in the Regulation of High-Density Lipoprotein Functionality and in Cardiovascular Protection.
Khalil A; Fulop T; Berrougui H
Antioxid Redox Signal; 2021 Jan; 34(3):191-200. PubMed ID: 31969002
[No Abstract] [Full Text] [Related]
11. Antioxidant and anti-inflammatory role of paraoxonase 1: implication in arteriosclerosis diseases.
Litvinov D; Mahini H; Garelnabi M
N Am J Med Sci; 2012 Nov; 4(11):523-32. PubMed ID: 23181222
[TBL] [Abstract][Full Text] [Related]
12. Association of serum amyloid A and oxidative stress with paraoxonase 1 in sarcoidosis patients.
Ivanišević J; Kotur-Stevuljević J; Stefanović A; Spasić S; Vučinić Mihailović V; Videnović Ivanov J; Jelić-Ivanović Z
Eur J Clin Invest; 2016 May; 46(5):418-24. PubMed ID: 26919159
[TBL] [Abstract][Full Text] [Related]
13. Paraoxonases role in the prevention of cardiovascular diseases.
Rosenblat M; Aviram M
Biofactors; 2009; 35(1):98-104. PubMed ID: 19319852
[TBL] [Abstract][Full Text] [Related]
14. The role of paraoxonase 1 activity in cardiovascular disease: potential for therapeutic intervention.
Mackness MI; Durrington PN; Mackness B
Am J Cardiovasc Drugs; 2004; 4(4):211-7. PubMed ID: 15285696
[TBL] [Abstract][Full Text] [Related]
15. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
Rosenblat M; Karry R; Aviram M
Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
[TBL] [Abstract][Full Text] [Related]
16. Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis.
Liberopoulos EN; Papavasiliou E; Miltiadous GA; Cariolou M; Siamopoulos KC; Tselepis AD; Elisaf MS
Perit Dial Int; 2004; 24(6):580-9. PubMed ID: 15559488
[TBL] [Abstract][Full Text] [Related]
17. Serum paraoxonase enzyme activity and oxidative stress in obese subjects.
Aslan M; Horoz M; Sabuncu T; Celik H; Selek S
Pol Arch Med Wewn; 2011 Jun; 121(6):181-6. PubMed ID: 21694681
[TBL] [Abstract][Full Text] [Related]
18. Importance of paraoxonase 1 (PON1) as an antioxidant and antiatherogenic enzyme in the cardiovascular complications of type 2 diabetes: Genotypic and phenotypic evaluation.
Shokri Y; Variji A; Nosrati M; Khonakdar-Tarsi A; Kianmehr A; Kashi Z; Bahar A; Bagheri A; Mahrooz A
Diabetes Res Clin Pract; 2020 Mar; 161():108067. PubMed ID: 32044348
[TBL] [Abstract][Full Text] [Related]
19. Activity of paraoxonase 1 and lipid profile in healthy children.
Sumegová K; Nagyová Z; Waczulíková I; Zitnanová I; Duracková Z
Physiol Res; 2007; 56(3):351-357. PubMed ID: 16792468
[TBL] [Abstract][Full Text] [Related]
20. Role of polyphenols and polyphenol-rich foods in the modulation of PON1 activity and expression.
Martini D; Del Bo' C; Porrini M; Ciappellano S; Riso P
J Nutr Biochem; 2017 Oct; 48():1-8. PubMed ID: 28623808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
